VIVOSTAT A/S: Financial statements 2022
CVR: 10033365
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
VIVOSTAT A/S (CVR 10033365) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 13,848,197 and a net result of DKK 5,668,024 compared with DKK -2,469,537 the year before. That is an increase of 158.7% compared with the year before. Equity in the 2022 report amounted to DKK 24,443,745. The solvency ratio was 83.2%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 13,848,197
- Profit/Loss
- DKK 5,668,024
- Equity
- DKK 24,443,745
- Total Assets
- DKK 29,376,570
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 13.8M | 5.7M | 24.4M | 10 |
| 2021 | - | 5.4M | -2.5M | 18.8M | 10 |
| 2020 | - | 11.3M | 3.4M | 21.2M | 10 |
| 2019 | - | 11.6M | 2.3M | 19.3M | 9 |
| 2018 | - | 11.7M | 2.4M | 18M | 10 |
Official annual report
Keep an eye on VIVOSTAT A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout VIVOSTAT A/S
VIVOSTAT A/S is a Danish company of the type Aktieselskab based in Allerød, founded in 2000. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named VIVOLUTION A/S. The management consists of Marko Rackovic. The board consists of Dr. Peter Leopold Maier (chair), Marko Rackovic and Viktor Alexander Maier. The company is owned by Vivostat International GmbH. The company has 10 employees (2026). In 2026, the company reported a gross profit of DKK 13,966,645 and a net result of DKK 1,466,266 compared with DKK 3,338,866 the year before. Equity in the 2026 report amounted to DKK 28,750,729.